Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hypoxia × fluoromisonidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Gastrointestinal 1

Conditions

Lung Neoplasms 1 Liver Neoplasms 1 Hypoxia 1 Head and Neck Neoplasms 1

Interventions

TH 302 2 pomalidomide 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Injections 1 Ethiodized Oil 1 Dexamethasone 1 Cyclophosphamide 1 Bortezomib 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Siemens Molecular Imaging

Phase 1/2 Completed

GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡